No adverse affect on sperm quality 6 to 14 months post BNT162b2 COVID vaccine Sperm Vaccine Coronavirus Disease COVID UChiPritzker HebrewU
Study: Sperm quality is not affected by the BNT162b2 mRNA SARS-CoV-2 vaccine: results of a 6–14 months follow-up. Image Credit: Yurchanka Siarhei / Shutterstock
Studies investigating the impact of COVID-19 vaccination on sperm health have shown that vaccines are safe for use in men. However, most of these studies have examined only the short-term effects of COVID-19 vaccination. The analysis of long-term outcomes is particularly needed to increase vaccine uptake and decrease vaccine hesitancy among men.
Related StoriesSemen samples were collected from the participants before vaccination and 6 to 14 months after vaccination. The samples were analyzed for semen volume, total motile count, sperm concentration, motility, and morphology. The analysis of pre- and post-vaccination semen samples revealed no significant differences in any tested parameters, including semen volume, total motile count, sperm concentration, morphology, and motility.